Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
ENTA
ENTA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ENTA News
Agios Pharmaceuticals (AGIO) Shares Surge 18.6% Following FDA Approval of Aqvesme
Dec 26 2025
NASDAQ.COM
JP Morgan Begins Coverage of Enanta Pharmaceuticals (ENTA) with Positive Outlook
Nov 15 2025
NASDAQ.COM
Microsoft Analyst Starts Coverage Optimistically; Check Out the Top 3 Initiations for Friday
Nov 14 2025
Benzinga
Enanta Shares Climb Following J.P. Morgan's Overweight Rating on RSV Treatment
Nov 14 2025
SeekingAlpha
Enanta Pharmaceuticals Unveils Latest Findings on Zelicapavir and EDP-323, Its N-Protein and L-Protein Inhibitors for Respiratory Syncytial Virus (RSV) Treatment, at IDWeek™ 2025
Oct 20 2025
Newsfilter
Enanta Pharmaceuticals Completes Stock Offering
Oct 02 2025
Yahoo Finance
Jefferies Boosts Enanta Pharma Rating to Buy and Increases Price Target to $20
Oct 01 2025
Benzinga
Major Stock Movers on Wednesday: LAC, NKE, and Others
Oct 01 2025
SeekingAlpha
Enanta Pharmaceuticals Reveals Pricing for Increased Public Offering of Common Stock
Oct 01 2025
Newsfilter
Enanta Pharmaceuticals Announces $65 Million Common Stock Offering
Oct 01 2025
SeekingAlpha
Enanta's RSV Medication Demonstrates Potential to Reduce Recovery Time for High-Risk Adults
Sep 29 2025
Benzinga
Enanta's Stock Increases Even After RSV Trial Falls Short of Primary Objective
Sep 29 2025
SeekingAlpha
Enanta Pharmaceuticals Announces Encouraging Phase 2b Study Results for Zelicapavir in Treating Respiratory Syncytial Virus (RSV) in High-Risk Adults
Sep 29 2025
Newsfilter
Merus Shares Surge 38%; Check Out 20 Stocks Making Moves in Premarket Trading
Sep 29 2025
Benzinga
Major Stock Movers on Monday: GSK, MLTX, and Others
Sep 29 2025
SeekingAlpha
Biotech Surge on Friday: Clinical Advancements Drive Afternoon Gains
Sep 29 2025
NASDAQ.COM
Show More News
